Cargando…

Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases

In recent years, better knowledge of the pathophysiology of inflammatory bowel diseases (IBD) has led to a relevant expansion of the therapeutic arsenal for these conditions. Janus kinase (JAK) inhibitors are a family of small molecules that block one or more of the intracellular tyrosine kinases, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez, Paulina, Quera, Rodrigo, Yarur, Andres J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010235/
https://www.ncbi.nlm.nih.gov/pubmed/36913180
http://dx.doi.org/10.1007/s40265-023-01840-5